Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway ; volume:16 ; number:1 ; day:27 ; month:8 ; year:2015 ; pages:1-8 ; date:12.2015
BMC nephrology ; 16, Heft 1 (27.8.2015), 1-8, 12.2015
- Creator
-
You, Yanwu
- Contributor
-
Qin, Yueqiu
Lin, Xu
Yang, Fafen
Li, Jun
Sooranna, Suren R.
Pinhu, Liao
SpringerLink (Online service)
- DOI
-
10.1186/s12882-015-0145-y
- URN
-
urn:nbn:de:1111-201611059698
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- You, Yanwu
- Qin, Yueqiu
- Lin, Xu
- Yang, Fafen
- Li, Jun
- Sooranna, Suren R.
- Pinhu, Liao
- SpringerLink (Online service)
Other Objects (12)
Funktion von CD3+-B220+-T-Zellen aus MRL-lpr-lpr-Mäusen
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
Immunomodulatory effects of atorvastatin on MRL/lpr mice
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
Untersuchung des Einflusses von BM 41 209 (Nachfolgesubstanz von Imexon) auf das MRL-lpr/lpr-Mausmodell
Proteasominhibition als Therapie zur Behandlung der Lupusnephritis im MRL-lpr-Mausmodell
The Fas receptor in normal and lupus-prone, MRL-lpr/lpr mice : analysis of the genetic defect in lpr mice and the expression of the apoptosis-inducing Fas receptor in lymphocytes of normal and autoimmune mouse strains
Analysis of C4 and the C4 binding protein in the MRL/lpr mouse
Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice
Triple‐threat quantitative multiplexed plasma proteomics analysis on immune complex disease MRL‐lpr mice
Funktion von CD3+-B220+-T-Zellen aus MRL-lpr-lpr-Mäusen
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
Immunomodulatory effects of atorvastatin on MRL/lpr mice
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
Untersuchung des Einflusses von BM 41 209 (Nachfolgesubstanz von Imexon) auf das MRL-lpr/lpr-Mausmodell
Proteasominhibition als Therapie zur Behandlung der Lupusnephritis im MRL-lpr-Mausmodell
The Fas receptor in normal and lupus-prone, MRL-lpr/lpr mice : analysis of the genetic defect in lpr mice and the expression of the apoptosis-inducing Fas receptor in lymphocytes of normal and autoimmune mouse strains
Analysis of C4 and the C4 binding protein in the MRL/lpr mouse
Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice
Triple‐threat quantitative multiplexed plasma proteomics analysis on immune complex disease MRL‐lpr mice
Funktion von CD3+-B220+-T-Zellen aus MRL-lpr-lpr-Mäusen
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
Immunomodulatory effects of atorvastatin on MRL/lpr mice
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
Untersuchung des Einflusses von BM 41 209 (Nachfolgesubstanz von Imexon) auf das MRL-lpr/lpr-Mausmodell
Proteasominhibition als Therapie zur Behandlung der Lupusnephritis im MRL-lpr-Mausmodell
The Fas receptor in normal and lupus-prone, MRL-lpr/lpr mice : analysis of the genetic defect in lpr mice and the expression of the apoptosis-inducing Fas receptor in lymphocytes of normal and autoimmune mouse strains
Analysis of C4 and the C4 binding protein in the MRL/lpr mouse
Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice